greeksoup/ stock research

Sabra Health Care REIT (SBRA) FY2014 results: revenue $184 million, up 36.2% on the year

Sabra Health Care REIT, Inc. (SBRA) reported revenue of $184 million for fiscal 2014, the year ended 31 December 2014, up 36.2% on the year before. Net income was $47 million, up 39.3%, and diluted earnings per share $0.78. The figures are the company's own, from the 10-K it filed with the SEC on 19 February 2015.

Revenue
$184 million
+36.2% on the year
FY2011FY2014
Operating margin
n/a
FY2011FY2014
Net income
$47 million
+39.3% on the year
FY2011FY2014
Diluted EPS
$0.78
+14.7% on the year
FY2011FY2014

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2014FY2013FY2012On the yearLast 8 years
Revenue184135103+36.2%
Interest expense47.040.534.3+16.1%
Pre-tax incomen/an/a19.5
Income tax0.00.00.0
Effective tax raten/an/a0.0%
Net income47.033.719.5+39.3%
Net margin25.6%25.0%18.9%
Diluted EPS$0.78$0.68$0.52+14.7%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2014FY2013FY2012On the yearLast 8 years
Operating cash flow85.362.156.3+37.4%
Cash from investing-826-298-219
Cash from financing799223137+258.7%
Depreciation and amortisation43.333.330.3+30.2%
Share-based compensation9.97.88.3+26.0%
Dividends paid81.558.248.9+40.1%
Dividend per share$1.51$1.36$1.32+11.0%
Diluted shares, weighted47m38m37m+23.2%
Shares outstanding at period end59m39m37m+52.2%

Balance sheet

$ millionFY2014FY2013FY2012On the yearLast 8 years
Shareholders' equity942460305+104.7%
Non-controlling interest0.00.0n/a
Debt1,092688575+58.7%
Other liabilities31.025.435.9+22.0%
Total liabilities and equity2,0651,174917+75.9%
Loans235n/an/a
Cash and equivalents61.84.317.1+1,334.4%
Other assets1,7681,169900+51.2%
Total assets2,0651,174917+75.9%

10-K for the year ended 31 December 2014, filed 19 February 2015: the filing.